Which Terpene Is an Appetite Suppressant?

β-Caryophyllene, a terpene found in black pepper, rosemary, cloves, and cannabis, is the most researched terpene for appetite suppression. In preclinical studies, it reduced the drive to seek out sweet, calorie-dense food by acting on the same receptor system that cannabinoids use, but through a pathway that curbs cravings rather than stimulating them. A handful of other terpenes, particularly d-limonene, also show anti-obesity effects in animal models. The evidence is promising but still almost entirely from rodent studies, and the gap between a mouse losing interest in sugar pellets and a person eating less at dinner is wide.

β-Caryophyllene and the CB2 Receptor

Most people associate the endocannabinoid system with THC and the munchies, so it feels counterintuitive that a compound working on part of the same system could suppress appetite. The distinction is which receptor gets activated. THC primarily hits the CB1 receptor, which ramps up hunger. β-Caryophyllene (often abbreviated BCP) binds selectively to the CB2 receptor, and in mouse studies, this had the opposite effect on food motivation. Mice given BCP showed significantly less drive to work for a sweet reward, and the effect disappeared when the CB2 receptor was blocked, confirming that the receptor was doing the heavy lifting.¹

BCP did not just reduce how much the mice ate; it also suppressed conditioned place preference for sweet food, which is a standard way researchers measure whether an animal has formed an emotional or habitual attachment to a reward. In plain terms, the mice stopped associating certain environments with the pleasure of eating something sweet. That makes BCP particularly interesting for researchers looking at food addiction-like behavior, not just overeating in general.¹

A comprehensive review of plant-derived compounds targeting obesity noted that BCP appears to have a dual action: it suppresses hunger signals and simultaneously enhances thermogenesis, the body’s process of generating heat by burning calories.² If that dual effect holds up in human trials, it would make BCP more attractive than a compound that only does one or the other. But “if” is doing a lot of work in that sentence, because no large human trials have been published yet.

D-Limonene and Fat Metabolism

D-limonene, the terpene responsible for the sharp citrus smell of lemon and orange peel, works through a completely different mechanism than BCP. Instead of targeting the brain’s reward circuitry, limonene appears to act on fat cells directly. In a study using both cell cultures and rats fed a high-calorie diet, d-limonene activated a metabolic switch called AMPK, which shifted fat cells away from storing lipids and toward breaking them down.³

Rats receiving limonene at a higher dose showed lower body weight, less total body fat, reduced LDL cholesterol, and higher HDL cholesterol compared to untreated controls. The study also found that limonene influenced the expression of genes involved in fat creation and fat breakdown, essentially dialing down the cellular machinery for making new fat while turning up the machinery for burning it.³

Whether d-limonene is truly an “appetite suppressant” depends on your definition. The rats ate a high-calorie diet throughout the study; limonene changed what their bodies did with the calories rather than necessarily reducing how much they ate. For people interested in weight management, the practical distinction between eating less and storing less may not matter much, but scientifically these are different outcomes with different implications. A terpene that reduces fat storage is not the same thing as one that makes you feel less hungry.

The Olfactory Route

Terpenes are volatile compounds, which means they evaporate easily and have strong smells. That matters because smell is one of the fastest shortcuts to the brain regions that control appetite. A systematic review of essential oils and fragrant compounds found that these aromatic molecules can regulate appetite through several pathways, including influencing leptin sensitivity, modulating the balance between hunger-promoting and satiety-promoting signals in the hypothalamus, and altering the activity of the sympathetic and parasympathetic nervous systems.⁴

This is relevant because many terpene products are marketed for aromatherapy rather than ingestion. Inhaling the scent of peppermint oil or grapefruit oil, both rich in terpenes, is a popular folk remedy for managing cravings. The biological plausibility is there: olfactory neurons connect directly to the hypothalamus, which is central command for hunger and fullness. But plausibility and proof are different things, and the human evidence for specific terpenes reducing appetite through smell alone remains thin. Most of the robust data still comes from animal models where the compounds were administered orally or injected.

What Happens in the Gut

Some terpenes affect appetite indirectly by changing how fast food moves through the digestive system. α-Pinene and β-pinene, the terpenes that give pine trees their characteristic scent and also appear in rosemary and eucalyptus, were found to speed up gastric emptying in rats. They decreased how long food sat in the stomach, increased stomach muscle tone, and accelerated the movement of a meal through the small intestine.⁵

Faster gastric emptying does not neatly translate to appetite suppression. In fact, if food leaves the stomach more quickly, you might feel hungry sooner, not later. The relevance here is more nuanced: gut motility and the timing of nutrient arrival in different segments of the intestine influence the release of satiety hormones. Depending on where and how terpenes act along the GI tract, the downstream effects on appetite could go in either direction. Pinene is not a straightforward appetite suppressant, but its gut effects are part of the broader picture of how terpenes interact with the systems that regulate eating behavior.

Thyme essential oil, which contains a blend of terpenes, showed a different kind of gut-related benefit in diabetic rats. At higher doses, it improved the balance of gut bacteria by reducing pathogenic species and protected the pancreas, liver, and kidneys from damage.⁶ Gut microbiome composition has been linked to obesity and appetite regulation in other research, so terpenes that shift the microbial balance in a favorable direction might have indirect effects on how hungry you feel. But the thyme study was specifically about diabetes management, and the gut microbiome connection to appetite is still being mapped out.

Why Terpenes Suppress Appetite in Nature

Terpenes did not evolve to help humans lose weight. Plants produce them as chemical defenses against herbivores, and the appetite-suppressing properties researchers are studying may simply be the human-relevant shadow of a strategy that evolved to make plants taste bad to animals trying to eat them. A study of woodrats foraging on juniper found that terpene content directly influenced feeding decisions: the animals preferentially chose trees with lower terpene levels and used behavioral strategies to minimize their terpene intake.⁷

This matters for understanding why so many different terpenes show some degree of appetite-related activity. It is not that plants independently evolved dozens of appetite suppressants for mammals. It is that mammals evolved to find terpene-rich plants less palatable, because eating too much of a plant’s defensive chemicals tends to be harmful. The “appetite suppression” observed in labs may partly reflect a deep-seated aversion response rather than a clean pharmacological suppression of hunger circuits. The practical difference for someone trying to manage their weight may be small, but understanding the evolutionary context helps explain why the effects are often modest and variable.

Safety and Dose Concerns

Terpenes are classified as “generally recognized as safe” (GRAS) by the FDA for use as food flavorings at the tiny concentrations found in food. But the doses used in animal appetite studies are much higher than what you would get from eating black pepper or sniffing a lemon. At elevated doses, some terpenes cause real problems. A review of terpene toxicity found that several monoterpenes, including limonene, and certain sesquiterpenes can cause liver damage, primarily through the formation of reactive metabolites and oxidative stress.⁸

The limonene finding is worth pausing on, because d-limonene is one of the terpenes most commonly discussed for weight management. The same compound that reduced body fat in rats at high doses also showed liver toxicity potential. Dose matters enormously. Essential oils are concentrated, and people sometimes treat “natural” as synonymous with “harmless,” which leads to overconsumption. Ingesting undiluted essential oils, a practice promoted by some wellness communities, can cause chemical burns to the esophagus and stomach lining in addition to any organ-level toxicity.

β-Caryophyllene has a somewhat better safety profile in the literature, partly because it targets CB2 receptors that are concentrated in immune and peripheral tissues rather than the central nervous system. It does not produce the psychoactive effects associated with CB1 activation. But “better safety profile” is relative; it means fewer red flags have appeared so far, not that high-dose supplementation has been proven safe in humans. Anyone considering terpene supplements for appetite control is essentially running their own uncontrolled experiment.

The Gap Between Animal Studies and Human Evidence

The honest state of the evidence is that no terpene has been validated as an appetite suppressant in large, well-designed human trials. The mouse data on BCP is compelling, and the rat data on d-limonene shows real metabolic effects, but rodent metabolism and feeding behavior differ from human metabolism and feeding behavior in important ways. Mice in a lab do not make emotional food choices, snack out of boredom, or eat differently because they had a stressful day.

This is not a problem unique to terpene research. The broader field of plant-derived anti-obesity compounds faces the same bottleneck. Even for THCV, a cannabinoid that has received more attention and investment than any individual terpene, a review of the clinical evidence noted that existing human trials are small and lack the statistical power to reach definitive conclusions.⁹ Terpene research is even further behind. The compounds are cheap and widely available, which ironically makes them less attractive for the kind of expensive clinical trials that would settle the question, because no one can patent black pepper.

The Marketing Problem

Walk into a dispensary or browse a supplement site and you will find products explicitly marketed as appetite suppressants based on their terpene profiles. The terpene content of a cannabis strain or an essential oil blend is often listed alongside specific health claims about weight loss, craving reduction, or metabolic support. These claims typically cite the same handful of animal studies discussed above, presented without any caveat about the lack of human data.

This pattern extends beyond terpenes to the broader CBD and cannabis wellness market. A review of CBD product labeling found that unsubstantiated health claims are common and may lead consumers to skip treatments that actually have evidence behind them.¹⁰ The same dynamic applies to terpene-based appetite claims. Someone who relies on a BCP supplement instead of addressing the behavioral, hormonal, or medical roots of their overeating is making a decision based on marketing, not on science that has been tested in people.

Supplement manufacturers are not required to prove that their products work before selling them; they only have to avoid claims that explicitly say the product treats or cures a disease. The language around terpenes and appetite often threads this needle carefully, using phrases like “supports healthy metabolism” or “may help manage cravings.” These claims sound modest, but they create an impression of validated efficacy that does not currently exist.

Which Terpene Profiles Show Up in Cannabis Strains

Cannabis strains are sometimes marketed based on their terpene content, with high-BCP or high-humulene strains promoted as less likely to trigger the munchies. Humulene, a close chemical relative of BCP that shares a similar ring structure, is often lumped in as another appetite-suppressing terpene, though the published evidence supporting this claim is thinner than what exists for BCP. The logic is that strains rich in these terpenes might counteract THC’s appetite-stimulating effects.

There is a kernel of biological plausibility here: if BCP activates CB2 receptors and reduces food-seeking behavior while THC activates CB1 receptors and increases it, the net effect of a strain containing both could differ from a strain that is mostly THC. But the ratio of these compounds in any given plant is small enough that the pharmacological impact of the terpene fraction, relative to the much larger dose of THC, is unclear. The idea that choosing a high-BCP cannabis strain will prevent the munchies oversimplifies a complex interaction that has not been quantified in humans.

Appetite regulation involves dozens of hormones, neurotransmitters, and brain regions working simultaneously. The review of plant-based anti-obesity compounds noted that hunger and fullness are governed by hypothalamic neurons and gut hormones including ghrelin, GLP-1, and PYY, with various plant compounds targeting different nodes in this network.² Any single terpene is hitting one or two of these targets at most. The expectation that a few milligrams of BCP in a cannabis strain will override the rest of the system is a stretch, even if the basic mechanism is real.

Practical Considerations If You Want to Try Terpenes

If you are curious about terpenes and appetite, the lowest-risk approach is dietary rather than supplemental. Black pepper, cloves, rosemary, oregano, and cinnamon are all rich in BCP. Citrus peel contains d-limonene. Cooking with these ingredients is safe at culinary doses and has been for thousands of years. You will not get the concentrated doses used in animal studies, but you also will not get the side effects.

Essential oil ingestion is riskier and largely unnecessary. The doses that showed effects in rats would be difficult to replicate safely in a human using over-the-counter essential oils, and the purity and composition of commercial essential oils varies widely. If you are already using essential oils in a diffuser, the aromatherapy route has at least some biological plausibility for appetite modulation, though the effect size in humans is unknown.

Terpene isolate supplements, sold as capsules or tinctures with standardized BCP or limonene content, sit in a regulatory gray zone. They are legal to sell but are not evaluated for efficacy, and their quality control varies by manufacturer. If you choose to try one, starting with a low dose and watching for digestive upset or signs of liver irritation, such as dark urine or upper abdominal pain, is common-sense risk management. Anyone taking medications metabolized by the liver should be particularly cautious, because terpenes can interact with the same enzyme systems that process many drugs.